Results 21 to 30 of about 31,034 (262)

Correction: Features of intermediate and late dry age-related macular degeneration on adaptive optics ophthalmoscopy: Pinnacle Study Report 8. [PDF]

Eye (Lond)
Hagag AM, Holmes C, Raza A, Riedl S, Anders P, Kaye R, Prevost T, Fritsche LG, Rueckert D, Bogunović H, Scholl HPN, Schmidt-Erfurth U, Lotery AJ, Sivaprasad S.   +13 more
europepmc   +3 more sources

Emerging Oral Pharmaceuticals for Dry Age-Related Macular Degeneration: Mechanism of Action, Current Clinical Status, and Future Directions. [PDF]

Ophthalmic Surg Lasers Imaging Retina
DeBoer CMT, Rasmussen DK, Franco JA, Mahajan VB.   +3 more
europepmc   +3 more sources

Treatment Methods Dry Form of Age Macular Degeneration — History and Prospects. Review

Oftalʹmologiâ, 2023
Age related macular degeneration is a leading cause of vision loss and an increasing problem of disability throughout the world among adults. That revue covers historical points, risk factors, pathogenesis, classification and current treatment ways of ...
A. N. Kulikov, M. V. Zakharov, A. A. Volozhev   +2 more
doaj   +1 more source

Treatment of Dry Age-Related Macular Degeneration [PDF]

Ophthalmic Research, 2014
A number of different approaches are under development for treating nonexudative manifestations of age-related macular degeneration (AMD). Some interventions target specific pathways that are believed to play a role in AMD pathogenesis, e.g. oxidative damage, lipofuscin accumulation, chronic inflammation (including complement activation), extracellular
Querques G, Rosenfeld PJ, Cavallero E, Borrelli E, Corvi F, Querques L, Bandello F, Zarbin MA   +7 more
openaire   +4 more sources

Recent Advances in Age-Related Macular Degeneration Therapies

Molecules, 2022
Age-related macular degeneration (AMD) was described for the first time in the 1840s and is currently the leading cause of blindness for patients over 65 years in Western Countries. This disease impacts the eye’s posterior segment and damages the macula,
Marie Fabre, Lou Mateo, Diana Lamaa, Stéphanie Baillif, Gilles Pagès, Luc Demange, Cyril Ronco, Rachid Benhida   +7 more
doaj   +1 more source

New Discoveries in Retinal Cell Degeneration and Retinal Diseases

Biomolecules, 2023
Age-related macular degeneration (AMD) has two phenotypes: dry AMD and wet AMD [...]
Puran S. Bora
doaj   +1 more source

Radiomic Characterization and Automated Classification of Drusen Substructure Phenotype Associated with High-Risk Dry Age-Related Macular Degeneration. [PDF]

Diagnostics (Basel)
Perkins SW, Shah N, Whitney J, Matar K, Yu HJ, Wykoff CC, Ehlers JP.   +6 more
europepmc   +2 more sources

Novel approach to antiangiogenic factors in age-related macular degeneration therapy

Central European Journal of Immunology, 2022
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss among the population above 85 worldwide. There are two main types of AMD: neovascular and dry AMD.
Katarzyna Samelska, Magdalena Kupis, Justyna Izdebska, Anna Kaminska, Piotr Skopiński   +4 more
doaj   +1 more source

Dry Age-Related Macular Degeneration Pharmacology [PDF]

, 2016
Age-related macular degeneration (AMD), the most common form of irreversible blindness in the industrially developed world, can present years before a patient begins to lose vision. For most of these patients, AMD never progresses past its early stages to the advanced forms that are principally responsible for the vast majority of vision loss. Advanced
Charles B, Wright, Jayakrishna, Ambati
openaire   +2 more sources

Circulating Anti-Endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration. [PDF]

Medicina (Kaunas)
Żuber-Łaskawiec K, Wilańska J, Karska-Basta I, Pociej-Marciak W, Romanowska-Dixon B, Sanak M, Kubicka-Trząska A.   +6 more
europepmc   +3 more sources